🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE

Recruitingn/aAges 18 Years - anyMaleAzienda Ospedaliero-Universitaria Careggi
NCT05022914 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational study was designed to evaluate progression free survival after PSMA-PET/CT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Signed informed consent * Age \>18 * Patient suitable for 68Ga-PSMA PET/CT re-staging according to clinical practice (Previous radical prostatectomy with histological result of Prostate adenocarcinoma +/- postoperative prostate bed radiotherapy (adjuvant or salvage setting), with a biochemical relapse defined as a PSA \> 0.2 and \<1 Exclusion Criteria: * ADT administration within 6 months from study enrollment * Persistent elevation of PSA after RP measured within 16 weeks from surgery (\> 0.1 ng/ml)
💊

What it tests

  • Not listed
📍

Where

1 site
AOU Careggi Radiation Oncology Unit
Florence, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy